Targeted next-generation sequencing as a diagnostic tool in gastrointestinal system cancer/polyposis patients
- PMID: 32390558
- DOI: 10.1177/0300891620919171
Targeted next-generation sequencing as a diagnostic tool in gastrointestinal system cancer/polyposis patients
Abstract
Background: Recent advances in next-generation sequencing (NGS) technology have enabled multigene testing and changed the diagnostic approach to hereditary gastrointestinal cancer/polyposis syndromes. The aim of this study was to analyze different cancer predisposition genes in hereditary/sporadic gastrointestinal cancer/polyposis.
Methods: Cancer predisposition genes were analyzed with an Illumina MiSeq NGS system in 80 patients with gastrointestinal cancer/polyposis who were examined between the years 2016 and 2019. Deletion/duplication analysis of MLH1, MSH2, and EPCAM genes was performed by using the multiplex ligation-dependent probe amplification method.
Results: Germline testing of hereditary cancer-related genes was performed in 80 patients with gastrointestinal cancer/polyposis. A total of 30 variants in 30 cases (37.5%) were assessed as pathogenic/likely pathogenic. A total of 19 heterozygous variants were assessed as variants of uncertain clinical significance in 17 cases (21.25%) and 18 (22.5%) novel variations (9 pathogenic/likely pathogenic, 9 variants of uncertain significance) were determined. In 4 (5%) cases, multiplex ligation-dependent probe amplification detected deletions in MLH1, MSH2, and EPCAM genes.
Conclusion: The accumulation of analyses with multigene testing will increase the available data for cancer predisposition genes in hereditary gastrointestinal cancer/polyposis. Educational campaigns for prevention, efficient screening programs, and more personalized care based on the profile of individual patients are necessary.
Keywords: Hereditary colorectal cancer/polyposis; genetic counseling; multigene testing; next-generation sequencing.
Similar articles
-
Development, technical validation, and clinical application of a multigene panel for hereditary gastrointestinal cancer and polyposis.Tumori. 2019 Aug;105(4):338-352. doi: 10.1177/0300891619847085. Epub 2019 May 8. Tumori. 2019. PMID: 31068090
-
Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologies.Fam Cancer. 2016 Oct;15(4):553-62. doi: 10.1007/s10689-016-9872-x. Fam Cancer. 2016. PMID: 26837502
-
Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.Scand J Gastroenterol. 2013 Jun;48(6):672-8. doi: 10.3109/00365521.2013.783102. Epub 2013 Apr 2. Scand J Gastroenterol. 2013. PMID: 23544471
-
Hereditary or sporadic polyposis syndromes.Best Pract Res Clin Gastroenterol. 2017 Aug;31(4):409-417. doi: 10.1016/j.bpg.2017.05.011. Epub 2017 Jun 6. Best Pract Res Clin Gastroenterol. 2017. PMID: 28842050 Review.
-
Update on genetic predisposition to colorectal cancer and polyposis.Mol Aspects Med. 2019 Oct;69:10-26. doi: 10.1016/j.mam.2019.03.001. Epub 2019 Mar 18. Mol Aspects Med. 2019. PMID: 30862463 Review.
Cited by
-
Functional analysis of MMR gene VUS from potential Lynch syndrome patients.PLoS One. 2024 Jun 6;19(6):e0304141. doi: 10.1371/journal.pone.0304141. eCollection 2024. PLoS One. 2024. PMID: 38843250 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous